Market Place
Sourcing Support
Bridgebio Oncology Grants Inducements Under Nasdaq LR 5635(C)(4)
13 Jan 2026 //
GLOBENEWSWIRE
BBOT To Present At J.P. Morgan Healthcare Conference
16 Dec 2025 //
GLOBENEWSWIRE
BBOT Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
11 Dec 2025 //
GLOBENEWSWIRE
BBOT Announces Late-Breaking Preclinical Data on BBO-10203
10 Dec 2025 //
GLOBENEWSWIRE
BBOT To Join December Investor Healthcare Conference
18 Nov 2025 //
GLOBENEWSWIRE
BBOT Updates Q3 2025 Financials & Corporate Advancements
12 Nov 2025 //
GLOBENEWSWIRE
BBOT To Attend Jefferies Global Healthcare Conference In London
03 Nov 2025 //
GLOBENEWSWIRE
BBOT Unveils Posters At San Antonio Breast Cancer Symposium
30 Oct 2025 //
GLOBENEWSWIRE
BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC
13 Oct 2025 //
GLOBENEWSWIRE
BBOT Exits SPAC Process, Ready To Execute After Private Stint
03 Sep 2025 //
BIOSPACE
BBOT to Join September Investor Healthcare Conferences
20 Aug 2025 //
GLOBENEWSWIRE
BBOT Goes Public, Targets KRAS and PI3K Pathway Cancers
11 Aug 2025 //
GLOBENEWSWIRE
BBOT: First Patient Dosed with PanKRAS Inhibitor in KONQUER-101
01 Apr 2025 //
BUSINESSWIRE
BBO-8520 Preclinical Data in KRASG12C Mutant Tumors Published
09 Dec 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.